A carregar...
Off-patent drugs at brand-name prices: a puzzle for policymakers
In August 2015, Turing Pharmaceuticals acquired the marketing rights to Daraprim (pyrimethamine), a drug used to treat parasitic infections like malaria and toxoplasmosis. Soon after, Turing caused an uproar when it announced that it would raise the price per tablet of Daraprim from [Formula: see te...
Na minha lista:
| Publicado no: | J Law Biosci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5033427/ https://ncbi.nlm.nih.gov/pubmed/27774247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jlb/lsw008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|